3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
124
Breast Neoplasms
83
Neoplasms
79
Colorectal Neoplasms
66
Neoplasm Metastasis
65
Leukemia, Myeloid, Acute
62
Prostatic Neoplasms
59
Recurrence
56
Ovarian Neoplasms
56
Pancreatic Neoplasms
53
Multiple Myeloma
51
Melanoma
39
Triple Negative Breast Neoplasms
37
Glioblastoma
36
Lung Neoplasms
35
Squamous Cell Carcinoma of Head and Neck
33
Lymphoma, Non-Hodgkin
33
Endometrial Neoplasms
33
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Carcinoma, Renal Cell
29
Lymphoma
28
Lymphoma, Large B-Cell, Diffuse
27
Carcinoma, Hepatocellular
27
Stomach Neoplasms
26
Small Cell Lung Carcinoma
26
Leukemia, Lymphocytic, Chronic, B-Cell
26
Lymphoma, B-Cell
25
Brain Neoplasms
25
Advanced Solid Tumor
25
Myelodysplastic Syndromes
24
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Hepatitis B
×
90 days
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled